2439-37-4

Basic information

• Product Name: L-Leucine, N,N-dimethyl-
• CAS NO: 2439-37-4
• Molecular Formula: C8H17NO2
• Molecular Weight: 159.228
• Mol File: 2439-37-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: L-Leucine, N,N-dimethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: L-Leucine, N,N-dimethyl-(2439-37-4)
• EPA Substance Registry System: L-Leucine, N,N-dimethyl-(2439-37-4)

Safety Data

• Hazardous Substances Data: 2439-37-4(Hazardous Substances Data)

Usage

General Description

L-Leucine, N,N-dimethyl is a chemical compound with the molecular formula C8H18N2O2. It is a derivative of the amino acid leucine, which is important for protein synthesis and muscle repair in the body. The N,N-dimethyl group in this compound refers to two methyl groups bonded to the nitrogen atom. L-Leucine, N,N-dimethyl has potential applications in pharmaceuticals and biotechnology, particularly in the development of new drugs or therapeutic agents. It may also be used as a research tool in biochemistry and molecular biology to study the role of leucine in cellular processes. Overall, this chemical compound has potential significance in various fields and industries.

Upstream product

• 123690-71-1 anorldianine 

Downstream Products

• 873951-99-6 Me₂Leu-Ser(Me₂Leu-Ser-MeLeu-MePhe)-MeLeu-MePhe-OH 
• 873951-96-3 Me₂Leu-Ser-MeLeu-MePhe-OH 
• 69150-45-4 (S)-2-(dimethylamino)-4-methyl-1-pentanol 
• 1185762-28-0 (N,N-dimethyl-L-leucinyl)-L-isoleucine benzyl ester 
• 298183-97-8 paliurine F 
• 69150-45-4 2-dimethylamino-4-methyl-pentan-1-ol 

Relevant articles and documents

Isolation and structure elucidation of cyclopeptide alkaloids from the leaves of Heisteria parvifolia

Heisteria parvifolia Sm. is prescribed in traditional medecine against numerous diseases in C?te d'Ivoire. Due to the shortcoming in scientifical knowledge of use of this species, our investigations revealed five undescribed cyclopeptide alkaloids added to one known derivative namely anorldianine. These compounds were elucidated by 1D and 2D-NMR experiments and comparison with literature data, and confirmed by HR-ESI-MS. Cytotoxic activity evaluation of these compounds against the chronic myeloid leukemia (K565) cell line exhibited an antiproliferative activity with cell growth inhibition from 13% to 46%.

Reduced dipeptide analogues as calcium channel antagonists

The present invention provides novel N-type calcium channel blockers, compositions comprising them, and methods of their use. The compounds of the invention are useful in the treatment of stroke, cerebral ischemia, pain, epilepsy, and head trauma. The nov